FDA recall D-1141-2015

AstraZeneca Pharmaceuticals LP · Class II · drug

Product

NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.

Reason for recall

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Distribution

Nationwide to wholesalers for further distribution at the retail level.

Key facts

Status
Terminated
Initiation date
2015-06-10
Report date
2015-06-24
Termination date
2016-09-27
Voluntary/Mandated
Voluntary: Firm initiated
Location
Wilmington, DE, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1141-2015